The Saudi Arabia heart valve devices market was valued at USD 758.12 Million in 2024, driven by the rising prevalence of cardiovascular diseases and substantial investment in healthcare infrastructure in the region. The market is anticipated to grow at a CAGR of 6.20% during the forecast period of 2025-2034, with the values likely to reach USD 1383.51 Million by 2034. Saudi Arabia's Vision 2030 initiative emphasizes healthcare infrastructure development, leading to enhanced cardiovascular care facilities and increased adoption of advanced medical technologies.

The size of the Cardiovascular Devices Market in Saudi Arabia market was valued at USD 0.76 Million in 2023 and is projected to reach USD 1.46 Million by 2032, with an expected CAGR of 9.81% during the forecast period. The Cardiovascular Devices Market in Saudi Arabia relates to the use of medical devices in diagnosing, treating and managing CAD, rhythm disorders and heart failure among other. Market products range from pacemaker, stents, defibrillator, heart valves to hospitals care products such as ECG machines among others. some of which are primary factors like rising cases of cardiovascular diseases attributable to emerging lifestyle diseases like obesity, diabetes and hypertension and secondary factors like an aging population. Increased investment on the healthcare infrastructure over years, technological enhancement observed in minimally invasive surgeries and adoption of advanced cardiovascular technology also contribute toward the market growth. Also, increased concern over heart diseases and enhancement in accessibility to the healthcare services is fuelling the market growth in Saudi Arabia. Recent developments include: May 2024: Bayer, in collaboration with Huma Therapeutics Limited, launched its innovative heart health screening tool in Saudi Arabia., July 2023: Imricor Medical Systems Inc. signed a distribution agreement with Al Faisaliah Medical Systems (FMS) Subsidiary of Tibbiyah Holding Company for distribution of products utilized in nearly 50,000 cardiac ablation procedures annually in Saudi Arabia.. Key drivers for this market are: Increasing Burden of Cardiovascular Diseases, Rapid Technological Advancements. Potential restraints include: High Cost of Instruments and Procedures. Notable trends are: The Electrocardiogram (ECG) Segment Holds the Majority Share of the Market, and it is Expected to Do the Same Over the Forecast Period.